Literature DB >> 29262758

Phase Relationship between DLMO and Sleep Onset and the Risk of Metabolic Disease among Normal Weight and Overweight/Obese Adults.

Kelly Glazer Baron1, Kathryn J Reid1, Lisa F Wolfe1, Hrayr Attarian1, Phyllis C Zee1.   

Abstract

Circadian misalignment is hypothesized to contribute to increased diabetes and obesity among shift workers and individuals with late sleep timing. Accordingly, the goal of our study was to identify-among normal and overweight/obese adults-associations between circadian timing (dim light melatonin onset; DLMO) and circadian misalignment (the interval between DLMO and sleep onset) with metabolic disease risk. This was a secondary analysis of data from a larger study. Participants ages 18 to 50 years without depression, diabetes, or shift work, with sleep duration 6.5 h or more, completed the following evaluations: 7 days of wrist actigraphy, circadian timing assessment (DLMO), and a fasting blood draw to measure glucose and insulin and calculate the Homeostatic Model of Assessment-Insulin Resistance (HOMA-IR). Data were analyzed using correlation and regression analyses controlling for age, sex, DLMO, and sleep duration. Analyses were conducted for the entire sample ( n = 54) and stratified by normal weight ( n = 36) and overweight/obese groups ( n = 18). Mean age was 26.4 years (SD = 7.1 years). Average sleep duration was 436.2 min (SD = 55.1 min), DLMO was 2250h (SD = 01:31), and interval between DLMO and sleep onset was 2 h 18 min (SD = 53 min). Average BMI was 24.3 kg/m2 (SD = 4.5 kg/m2). Circadian timing and interval between DLMO and sleep onset were not associated with glucose, insulin, or HOMA-IR in the main analyses. Among overweight/obese participants, a shorter interval between DLMO and sleep onset was associated with higher insulin ( B[SE] = -5.12 [2.24], p = 0.04) and HOMA-IR ( B[SE] = -1.32 [0.57], p = 0.04). Results of our multivariable model indicated that among overweight/obese participants, insulin was 5.1 pmol/L higher and HOMA was 1.3 µU/mL higher for every hour closer that sleep onset was to DLMO. The strengths of this study include the use of objective measures of circadian timing, but results should be considered hypothesis generating due to the small sample size and use of subgroup analyses.

Entities:  

Keywords:  HOMA; circadian misalignment; insulin; melatonin; sleep

Mesh:

Substances:

Year:  2017        PMID: 29262758      PMCID: PMC7201427          DOI: 10.1177/0748730417745914

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  25 in total

1.  Social jetlag and obesity.

Authors:  Till Roenneberg; Karla V Allebrandt; Martha Merrow; Céline Vetter
Journal:  Curr Biol       Date:  2012-05-10       Impact factor: 10.834

2.  Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance.

Authors:  Kenneth P Wright; Amanda L Drake; Danielle J Frey; Monika Fleshner; Christopher A Desouza; Claude Gronfier; Charles A Czeisler
Journal:  Brain Behav Immun       Date:  2015-01-29       Impact factor: 7.217

3.  Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin.

Authors:  A Voultsios; D J Kennaway; D Dawson
Journal:  J Biol Rhythms       Date:  1997-10       Impact factor: 3.182

4.  Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society.

Authors:  Nathaniel F Watson; M Safwan Badr; Gregory Belenky; Donald L Bliwise; Orfeu M Buxton; Daniel Buysse; David F Dinges; James Gangwisch; Michael A Grandner; Clete Kushida; Raman K Malhotra; Jennifer L Martin; Sanjay R Patel; Stuart F Quan; Esra Tasali
Journal:  Sleep       Date:  2015-06-01       Impact factor: 5.849

Review 5.  Circadian topology of metabolism.

Authors:  Joseph Bass
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

6.  Circadian misalignment increases cardiovascular disease risk factors in humans.

Authors:  Christopher J Morris; Taylor E Purvis; Kun Hu; Frank A J L Scheer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

7.  Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption.

Authors:  Orfeu M Buxton; Sean W Cain; Shawn P O'Connor; James H Porter; Jeanne F Duffy; Wei Wang; Charles A Czeisler; Steven A Shea
Journal:  Sci Transl Med       Date:  2012-04-11       Impact factor: 17.956

8.  Role of sleep timing in caloric intake and BMI.

Authors:  Kelly G Baron; Kathryn J Reid; Andrew S Kern; Phyllis C Zee
Journal:  Obesity (Silver Spring)       Date:  2011-04-28       Impact factor: 5.002

9.  Morning Circadian Misalignment during Short Sleep Duration Impacts Insulin Sensitivity.

Authors:  Robert H Eckel; Christopher M Depner; Leigh Perreault; Rachel R Markwald; Mark R Smith; Andrew W McHill; Janine Higgins; Edward L Melanson; Kenneth P Wright
Journal:  Curr Biol       Date:  2015-11-05       Impact factor: 10.834

10.  Circadian timing and alignment in healthy adults: associations with BMI, body fat, caloric intake and physical activity.

Authors:  K G Baron; K J Reid; T Kim; L Van Horn; H Attarian; L Wolfe; J Siddique; G Santostasi; P C Zee
Journal:  Int J Obes (Lond)       Date:  2016-10-31       Impact factor: 5.095

View more
  4 in total

Review 1.  Circadian disruption and human health: A bidirectional relationship.

Authors:  Sabra M Abbott; Roneil G Malkani; Phyllis C Zee
Journal:  Eur J Neurosci       Date:  2019-01-03       Impact factor: 3.386

Review 2.  Assessment of Circadian Rhythms.

Authors:  Kathryn J Reid
Journal:  Neurol Clin       Date:  2019-08       Impact factor: 3.806

3.  Association between sleep duration and albumin in US adults: a cross-sectional study of NHANES 2015-2018.

Authors:  Jingxian Li; Lizhong Guo
Journal:  BMC Public Health       Date:  2022-06-02       Impact factor: 4.135

4.  Circadian rhythm phase shifts caused by timed exercise vary with chronotype.

Authors:  J Matthew Thomas; Philip A Kern; Heather M Bush; Kristen J McQuerry; W Scott Black; Jody L Clasey; Julie S Pendergast
Journal:  JCI Insight       Date:  2020-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.